Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 67,367 shares at $28.95 ($1.9M) on 2016-05-02, disclosed to the SEC on 2016-05-04.
Open-market sale of $1.9M MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.95 | 35,438 | $1.0M | 53.1% |
| 2 | $29.59 | 8,249 | $244K | 12.6% |
| 3 | $27.80 | 16,338 | $454K | 23.5% |
| 4 | $28.44 | 7,142 | $203K | 10.5% |
| 5 | $29.32 | 200 | $6K | 0.3% |
| Total | $28.70 avg | 67,367 |
| $1.9M |
| 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |